Has Yaoming Gu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,262 in general payments to Yaoming Gu, MD across 577 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Yaoming Gu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Yaoming Gu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Yaoming Gu, MD

Interventional Pain Medicine · Richmond, VANPI 1265478184

Payments from drug & device makers

$13,262in general payments, 2019–2025

Across 577 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Collegium Pharmaceutical, Inc.$2K
Si-bone, Inc.$1K
Medtronic$812
AbbVie$792
Vertos Medical, Inc.$738
Boston Scientific$728
plus $8K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Collegium Pharmaceutical, Inc.	92	$1,583
Si-bone, Inc.	11	$1,017
Medtronic(2 entities)	23	$812
AbbVie	49	$792
Vertos Medical, Inc.	5	$738
Boston Scientific	49	$728
Abbott	21	$487
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	26	$448
Pfizer	23	$425
Averitas Pharma Inc.	14	$401
Scilex Pharmaceuticals Inc.	21	$381
GRT US Holding, Inc.	14	$329
MML US, Inc.	6	$284
Mallinckrodt Hospital Products Inc.	15	$284
Nevro Corp.	10	$259
Teva Pharmaceuticals USA, Inc.	17	$254
IBSA Pharma Inc.	11	$249
Spinal Simplicity, LLC	3	$240
Bioventus LLC	9	$208
Biohaven Pharmaceutical Holding Company Ltd.	10	$207
Foundation Fusion Solutions, LLC	1	$192
Arbor Pharmaceuticals, Inc.	11	$190
Johnson & Johnson	9	$184
Kowa Pharmaceuticals America, Inc.	18	$174
Lilly USA, LLC	13	$167
Forte Bio-pharma LLC	2	$144
Biotronik NRO, Inc.	1	$143
Beone Medicines USA, Inc.	1	$135
Vertex	7	$127
Merz Pharmaceuticals, LLC	5	$114
Tersera Therapeutics LLC	6	$113
Biodelivery Sciences International, Inc.	8	$107
Relievant Medsystems, Inc.	5	$104
Biohaven Pharmaceuticals, Inc.	4	$99
Novartis	5	$95
Globus Medical	2	$82
Amgen	5	$81
MDD US Operations, LLC	3	$64
Lundbeck LLC	3	$57
Redhill Biopharma Inc.	3	$53
SPR Therapeutics, Inc	2	$49
Axsome Therapeutics, Inc.	2	$44
Kaleo, Inc.	3	$43
Fidia Pharma USA Inc.	2	$37
Nalu Medical, Inc.	2	$37
Almatica Pharma LLC	2	$36
Assertio Therapeutics, Inc.	2	$36
Innovation Technologies Inc	1	$34
Pacira Therapeutics, Inc.	1	$31
Zimmer Biomet	1	$31
Painteq LLC	1	$30
Merz North America, Inc.	1	$29
Azurity Pharmaceuticals, Inc.	2	$29
Hikma Pharmaceuticals USA	2	$26
Tonix Medicines, Inc.	1	$24
Cumberland Pharmaceuticals, Inc.	1	$24
Kyowa Kirin, Inc.	1	$24
Pacira Pharmaceuticals Incorporated	1	$23
Curonix LLC	1	$23
Sentynl Therapeutics, Inc.	1	$19

How this compares

$13,262 in reported general payments places this provider in the 80th percentile of 52 interventional pain medicine providers in Virginia.

See all interventional pain medicine providers in Virginia →

Medicare billing

Part B allowed, 2024

$532,711

Medicare patients

469

Services billed

6,992

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Richmond

Benjamin SeemanRichmond$28K
Daniel MartinRichmond$4K
Elisabeth DoukliasRichmond$959
Talal GhazalArlington$248K
Ketan PatelHaymarket$133K
Che TorryNewport News$48K
Niteesh BhararaReston$25K
Sassan HassassianManassas$24K
Raj SurejaNewport News$23K
Alok GopalWinchester$16K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →